Browsing by Author Hajarizadeh, Behzad

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2017Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE studyWeltman, Martin; Amin, Janaki; Backmund, Markus; Bruggmann, Philip; Conway, Brian; Cunningham, Evan B.; Dalgard, Olav; et al, Various; Foster, Graham R; Hajarizadeh, Behzad; Hellard, Margaret; Nepean Clinical School: MedicineAdherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study, BMC Infectious Diseases, vol.17, 1, 2017,pp 1-12
2017Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE studyWeltman, Martin; Backmund, Markus; Bourgeois, Stefan; Bruggmann, Philip; Bruneau, Julie; Conway, Brian; Cunningham, Evan B.; Dunlop, Adrian; et al, Various; Hajarizadeh, Behzad; Midgard, Havard; Nepean Clinical School: MedicineChanges in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study, International Journal of Drug Policy, vol.47, N/A, 2017,pp 230-238
2014The Effects of Female Sex, Viral Genotype, and IL28B Genotype on Spontaneous Clearance of Acute Hepatitis C Virus InfectionGeorge, Jacob; Amin, Janaki; Bruneau, Julie; Cox, Andrea; et al, Various; Grebely, Jason; Hajarizadeh, Behzad; Morris, Meghan; Page, Kimberly; Rice, Thomas; Sacks-Davis, Rachel; Schim van der Loeff, Maarten; Western Clinical School: Westmead Millennium InstituteThe Effects of Female Sex, Viral Genotype, and IL28B Genotype on Spontaneous Clearance of Acute Hepatitis C Virus Infection, Hepatology, vol.59, 1, 2014,pp 109-120
2017Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE studyWeltman, Martin; Backmund, Markus; Bruggmann, Philip; Conway, Brian; Cunningham, Evan B.; Dalgard, Olav; et al, Various; Foster, Graham R; Grebely, Jason; Hajarizadeh, Behzad; Robaeys, Geert; Nepean Clinical School: MedicineEfficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study, International Journal of Drug Policy, vol.47, N/A, 2017,pp 177-186
2017Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regressionGeorge, Jacob; Amin, Janaki; Danta, Mark; Dore, Gregory; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Waziry, Reem; Westmead Clinical School: Westmead Institute for Medical ResHepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression, Journal of Hepatology, vol.67, 6, 2017,pp 1204-1212
2016Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDouglas, Mark; George, Jacob; Sheridan, David; Applegate, Tanya; Askew, Ben; Dore, Gregory J.; et al, .; Fenwick, Fiona; Hajarizadeh, Behzad; Matthews, Gail; Neely, Dermot; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResMaximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection, Liver International, vol.36, 12, 2016,pp 1774-1782
2016Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDouglas, Mark; George, Jacob; Sheridan, David; Applegate, Tanya; Askew, Ben; Dore, Gregory J.; et al, .; Fenwick, Fiona; Hajarizadeh, Behzad; Matthews, Gail; Neely, Dermot; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResMaximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection, Liver International, vol.36, 12, 2016,pp 1774-1782
2015Strategies to manage hepatitis C virus infection disease burden - Volume 3Muljono, David Handojo; Abaalkhail, Faisal; Alfaleh, Faleh; Alzaabi, Mohammed; et al, Various; Hajarizadeh, Behzad; Hunyady, Bela; Kim, Doyoung; Maticic, Mojca; Nugrahini, Naning; Tolmane, Ieva; Valantinas, Jonas; Medicine Faculty OfficeStrategies to manage hepatitis C virus infection disease burden - Volume 3, Journal of Viral Hepatitis, vol.22, Suppl. 4, 2015,pp 42-65
2017Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014)George, Jacob; Alavi, Maryam; Amin, Janaki; Dore, Gregory; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Matthews, Gail V; Waziry, Reem; Westmead Clinical School: Westmead Institute for Medical ResSurvival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014), Hepatology Communications, vol.1, 8, 2017,pp 736-747
2016Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: a population-based study, 1995-2012George, Jacob; Alavi, Maryam; Amin, Janaki; Dore, Gregory; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Western Clinical School: Westmead Institute for Medical ResTime to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: a population-based study, 1995-2012, Journal of Hepatology, vol.65, 5, 2016,pp 879-887
2016Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014)George, Jacob; Alavi, Maryam; Amin, Janaki; Dore, Gregory J.; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Matthews, Gail; Waziry, Reem; Western Clinical School: Westmead Institute for Medical ResTrends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014), Journal of Hepatology, vol.65, 6, 2016,pp 1086-1093